Jurors sided with Merck in a Vioxx trial late last week, according to a recent news article. The case concerned a 52-year-old Illinois woman named Patty Schwaller. Patty, an obese woman with diabetes and high blood pressure, had been taking Vioxx for nearly 2 years when she died from a heart attack in 2003. The…
Category Archives: Vioxx Lawsuits
Merck Loses Second Vioxx Trial
After a long silence, finally there’s news about Vioxx (from a AP article published today): NEW ORLEANS – Merck & Co. lost the second federal trial over its withdrawn painkiller Vioxx on Thursday and must pay $51 million to a retired FBI agent who had a heart attack after taking the drug for more than…
Vioxx Plaintiff Gets $13.5 Million
…but, of course, Merck plans to appeal. The 77-year-old man, who blamed his heart attack on Merck’s Vioxx, won $9 million today after already being awarded $4.5 million, bringing his grand total to $13.5 million. This was the 6th trial over Vioxx, and “the first involving people alleging use of 18 months or more.” That…
Vioxx class action in Australia
Australians are launching a class action against Merck over Vioxx: More than 400 Australians have launched a class action for personal damages from the manufacturers of the anti-arthritis drug, Vioxx. The drug has been found to increase the risk of stroke and heart attacks, and was globally recalled in September last year. Law firm Slater…
Vioxx Mistrial
The first federal lawsuit case against Merek & Co. has ended in a mistrial. Jury members were unable to reach a verdict. This is good and bad news for Merck & Co: Judge declares mistrial in federal Vioxx case Jurors deadlocked in federal trial against pain drug maker Merck Updated: 3:08 p.m. ET Dec. 12,…
More Vioxx Drama
Vioxx’s stocks have taken a huge hit after new allegations were published by the New England Journal of Medicine: Vioxx jury deliberates amid new blow CHICAGO (Reuters) – As the first federal jury deliberates whether Merck & Co.’s painkiller Vioxx contributed to a Florida man’s death, investors on Friday digested new claims that the battered…
Vioxx study data knowingly skewed
An editorial in the New England Journal of Medicine claims that “authors of a study funded by Vioxx maker Merck & Co. failed to disclose in a report published in the New England Journal of Medicine in 2000 that three additional patients in a clinical study suffered heart attacks while using the now-withdrawn painkiller,” according…
News on the upcoming Vioxx trial
Vioxx users will challenge safety claims, according to Yahoo! News: HOUSTON – Whether the once-popular painkiller Vioxx can be lethal if taken for just a few weeks will be the crux of the first federal trial concerning the drug’s safety, plaintiff’s lawyers said Wednesday. Jere Beasley and Andy Birchfield, the Montgomery, Ala., lawyers representing the…
Class action kings move to NY
TheLawyer.com is reporting that “Houston-based Lanier Law Firm has launched in New York with four lawyers, with the aim of expanding the presence to eclipse its headquarters within three years.” Officially opened today (16 November), the mid-town Manhattan office of the class action specialists will be overseen by resident head Richard Meadow, who will be…
Next Vioxx case will be tough for Merck, lawyers say
AP Business Writer Linda A. Johnson reports: TRENTON, N.J. – The next Vioxx product-liability case to come to trial in New Jersey will likely be a tougher battle for manufacturer Merck & Co., which last week got its first courtroom victory in a case involving short-term use of the now-withdrawn painkiller. New Jersey Superior Court…